CTRA vs LAB · P/E 15, rev $5.46B vs rev $174.4M
Coterra Energy Inc (CTRA) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CTRA currently screens at market cap $20.46B and trailing P/E 15.2. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CTRA and LAB stock pages for the full models.
Not investment advice.